Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Sarcoma 39Dendritic Cell Sarcoma, Interdigitating 30Lymphoma 22Burkitt Lymphoma 22Lymphoma, Large B-Cell, Diffuse 20Osteosarcoma 17Neuroectodermal Tumors, Primitive, Peripheral 17Lymphoma, Non-Hodgkin 17Precursor Cell Lymphoblastic Leukemia-Lymphoma 16Leukemia 15Lymphoma, Large-Cell, Immunoblastic 14Lymphoma, Mantle-Cell 12Lymphoma, Follicular 12Leukemia, Myeloid, Acute 12Leukemia, Lymphocytic, Chronic, B-Cell 12Rhabdomyosarcoma 11Lymphoma, B-Cell, Marginal Zone 11Sarcoma, Ewing 10Recurrence 10Neuroblastoma 10Blast Crisis 10Leukemia, Myeloid, Accelerated Phase 9Central Nervous System Neoplasms 9Neoplasms, Plasma Cell 8Myelodysplastic Syndromes 8Multiple Myeloma 8Leukemia, Myeloid, Chronic-Phase 8Hodgkin Disease 8Brain Neoplasms 8Myeloproliferative Disorders 7

Interventions

Doxorubicin 25Gemcitabine 16Trabectedin 12Ifosfamide 12Radiotherapy 11Docetaxel 10Dacarbazine 8pazopanib 7Nivolumab 6Specimen Handling 5Biopsy 5liposomal doxorubicin 4Temozolomide 4pembrolizumab 3Sunitinib 3Sorafenib 3Radiation 3Magnetic Resonance Spectroscopy 3Filgrastim 3rucaparib 2pegfilgrastim 2olaratumab 2eribulin 2durvalumab 2cixutumumab 2cemiplimab 2brostallicin 2belinostat 2avelumab 2X-Rays 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Leiomyosarcoma × Etoposide × Sarcoma × Clear all
NCT00003052 2013-09-17

Combination Chemotherapy With or Without Hyperthermia Therapy in Treating Patients With Soft Tissue Sarcoma

National Cancer Institute (NCI)

Phase 3 Completed
340 enrolled
Sarcoma

Fibrosarcoma, Hemangiosarcoma, Leiomyosarcoma, Liposarcoma, Rhabdomyosarcoma, Sarcoma, Sarcoma, Synovial, Neurofibrosarcoma, Histiocytoma, Malignant Fibrous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡